Literature DB >> 12689919

Isolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteins.

Chao-yuh Yang1, Joe L Raya, Hsin-Hung Chen, Chu-Huang Chen, Yasunori Abe, Henry J Pownall, Addison A Taylor, Charles V Smith.   

Abstract

OBJECTIVE: Current evidence suggests that oxidatively modified human plasma low-density lipoproteins (ox-LDLs) are proatherogenic and cytotoxic to endothelial and vascular smooth muscle cells. The present study describes a method using ion-exchange chromatography that is capable of large-scale subfractionation of LDL for adequate analyses of composition or bioactivities. METHODS AND
RESULTS: LDLs from normolipidemic (N-LDL) and homozygous familial hypercholesterolemic (FH-LDL) subjects were separated into 5 subfractions (L1 through L5) by high-capacity ion-exchange chromatography. The most strongly retained fraction from FH subjects, FH-L5, suppressed DNA synthesis in cultured bovine aortic endothelial cells and stimulated mononuclear cell adhesion to cultured endothelial cells under flow conditions in vitro. L5, which represented 1.1+/-0.2% and 3.7+/-1.7% of the LDL from N-LDL and FH-LDL, respectively, was more triglyceride-rich (17% versus 5%) and cholesteryl ester-poor (23% versus 33%) than were L1 through L4. Electrophoretic mobilities on agarose gels increased from L1 to L5. According to SDS-PAGE, apolipoprotein B-100 in N-LDL fractions L1 through L5 appeared as a single approximately 500-kDa band. In contrast, the fractions isolated from FH-LDL showed substantial fragmentation of the apolipoprotein B-100, including bands between 200 and 116 kDa. Competitive ELISA analyses using a malondialdehyde-specific monoclonal antibody against Cu2+ ox-LDL suggest that FH-L5 is malondialdehyde-modified.
CONCLUSIONS: Relative to N-LDL, FH-LDL contains higher concentrations of a fraction, L5, that exhibits distinctive physicochemical properties and biological activities that may contribute to initiation and progression of atherogenesis in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12689919     DOI: 10.1161/01.ATV.0000071350.78872.C4

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  28 in total

1.  Biochemical and functional characterization of charge-defined subfractions of high-density lipoprotein from normal adults.

Authors:  Ju-Yi Hsieh; Chiz-Tzung Chang; Max T Huang; Chia-Ming Chang; Chia-Ying Chen; Ming-Yi Shen; Hsin-Yi Liao; Guei-Jane Wang; Chu-Huang Chen; Chao-Jung Chen; Chao-Yuh Yang
Journal:  Anal Chem       Date:  2013-11-13       Impact factor: 6.986

Review 2.  Lipoprotein-associated phospholipase A2: pathogenic mechanisms and clinical utility for predicting cardiovascular events.

Authors:  Vijay Nambi; Christie M Ballantyne
Journal:  Curr Atheroscler Rep       Date:  2006-09       Impact factor: 5.113

Review 3.  Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship?

Authors:  Ayse Bag-Ozbek; Jon T Giles
Journal:  Curr Allergy Asthma Rep       Date:  2015-02       Impact factor: 4.806

4.  Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation.

Authors:  Juliana Hwang; Michael H Ing; Adler Salazar; Bernard Lassègue; Kathy Griendling; Mohamad Navab; Alex Sevanian; Tzung K Hsiai
Journal:  Circ Res       Date:  2003-10-30       Impact factor: 17.367

Review 5.  The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis.

Authors:  Salim S Virani; Vijay Nambi
Journal:  Curr Atheroscler Rep       Date:  2007-08       Impact factor: 5.113

6.  Chemical composition-oriented receptor selectivity of L5, a naturally occurring atherogenic low-density lipoprotein.

Authors:  Liang-Yin Ke; David A Engler; Jonathan Lu; Risë K Matsunami; Hua-Chen Chan; Guei-Jane Wang; Chao-Yuh Yang; Jan-Gowth Chang; Chu-Huang Chen
Journal:  Pure Appl Chem       Date:  2011       Impact factor: 2.453

Review 7.  Inflammation, lipid metabolism and cardiovascular risk in rheumatoid arthritis: A qualitative relationship?

Authors:  Carmen García-Gómez; Maria Bianchi; Diana de la Fuente; Lina Badimon; Teresa Padró; Emili Corbella; Xavier Pintó
Journal:  World J Orthop       Date:  2014-07-18

Review 8.  The underlying chemistry of electronegative LDL's atherogenicity.

Authors:  Liang-Yin Ke; Nicole Stancel; Henry Bair; Chu-Huang Chen
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

9.  Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation.

Authors:  Hua-Chen Chan; Liang-Yin Ke; Chih-Sheng Chu; An-Sheng Lee; Ming-Yi Shen; Miguel A Cruz; Jing-Fang Hsu; Kai-Hung Cheng; Hsiu-Chuan Bonnie Chan; Jonathan Lu; Wen-Ter Lai; Tatsuya Sawamura; Sheng-Hsiung Sheu; Jeng-Hsien Yen; Chu-Huang Chen
Journal:  Blood       Date:  2013-09-12       Impact factor: 22.113

10.  DNA hypermethylation: A novel mechanism of CREG gene suppression and atherosclerogenic endothelial dysfunction.

Authors:  Yanxia Liu; Xiaoxiang Tian; Shan Liu; Dan Liu; Yang Li; Meili Liu; Xiaolin Zhang; Chenghui Yan; Yaling Han
Journal:  Redox Biol       Date:  2020-01-31       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.